Vanguard Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329M Buy
2,411,171
+14,660
+0.6% +$1.8M 0.01% 873
2026
Q1
$282M Buy
+2,396,511
New +$335M 0.01% 882

Other funds holding RGEN

Vanguard Capital Management's RGEN Position: Q2 2026 in Review

Vanguard Capital Management increased its Repligen (RGEN) stake by 0.61% in Q2 2026, buying an estimated $1.8M and bringing the position to 2,411,171 shares worth $329M. The position accounts for 0.01% of the portfolio, ranked #873.

Vanguard Capital Management first reported a position in RGEN in Q1 2026 and has held it in 2 quarters since. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Vanguard Capital Management held 2,411,171 shares of Repligen worth $329M as of Q2 2026.
  • Vanguard Capital Management bought 14,660 Repligen shares in Q2 2026, an estimated $1.8M.
  • Repligen made up 0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #873 holding.
  • Vanguard Capital Management first reported a position in Repligen in Q1 2026 and has held it in 2 quarters since.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.